-
Monetary Risk Preferences and Demand for Preventative Treatment: A Discrete Choice Experiment Among Individuals at High Risk for Lung Cancer
10 Feb 2026 22:11 GMT
… help explain factors behind vaccine hesitancy, particularly toward the … COVID-19 vaccines, for which global vaccine hesitancy rates … shots, the COVID-19 vaccine), or other measures to … getting lung cancer, and a relative risk of getting lung cancer compared …
-
Independent Risk Factors and Nomogram-Based Prediction of Pulmonary Fungal Infection in Lung Cancer Inpatients: A Single-Center Retrospective Study
10 Feb 2026 22:10 GMT
… in consecutively hospitalized lung cancer patients, incorporating cellular … infection among hospitalized lung cancer patients, indicating that … immune defense, immunotherapies and vaccines. Adv. Drug Deliv … non-small cell lung cancer. Clin Lung Cancer. 2022;23( …
-
Mutant KRAS Vaccine Boosts Pancreatic Cancer Therapy
11 Feb 2026 03:25 GMT
… This reinforces the vaccine and immunotherapy combination … and lung cancers, suggesting that similar vaccine and checkpoint … cancer patientsmutant KRAS vaccinenovel therapeutic strategies … based immunogenpersonalized cancer vaccinesresilience of pancreatic …
-
National opinion: Arizona Republicans should stop trying to ban mRNA vaccines
10 Feb 2026 13:57 GMT
… promise for treating melanoma, lung cancer, breast cancer, and prostate … found that mRNA cancer vaccines could save "tens … and autoimmune diseases. mRNA vaccines also provide crucial protection … hundreds of deaths. These vaccines can also lessen the …
-
Inhalation: A Smart Strategy and Increasing Potential for Drug Delivery
11 Feb 2026 17:18 GMT
… feasible and effective for treating lung tumors with reduced systemic side-effects … insulins (eg, Afrezza), pain medications, vaccines, lung cancer therapeutics, and drugs for gene … delivering monoclonal antibodies to treat lung tumors. Pharm Res. 2011;28(9 …
-
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment
11 Feb 2026 17:30 GMT
… in metastatic non–small cell lung cancer (NSCLC), serious adverse … resection.
Non-Small Cell Lung Cancer
KEYTRUDA and KEYTRUDA QLEX … metastatic nonsquamous non–small cell lung cancer (NSCLC), with no … of important medicines and vaccines. We aspire to be …
-
Socialism’s biotechnology success
11 Feb 2026 15:13 GMT
… pharmaceutical products (such as vaccines and medicines) reached … attack treatment, and novel vaccines developed for meningitis, … a therapeutic vaccine for a form of lung cancer has been … . Under these circumstances, vaccines are simply another commodity …
-
Elastomeric Infusion Pumps Market to Reach USD 3.14 Billion by 2036 on Outpatient Care Growth
11 Feb 2026 12:50 GMT
… /reports/lung-cancer-surgery-market
Veterinary Vaccines Market https:/… /reports/veterinary-vaccines-market
Lung Cancer Therapeutics Market https:/… com/reports/lung-cancer-therapeutics-market
Home Healthcare Software …
-
Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women, 1990–2021: Evidence from the GBD Study
11 Feb 2026 09:40 GMT
… inadequate screening, low HPV vaccine coverage, and limited health … of tracheal, bronchus, and lung cancer attributed to particulate matter … in the context of vaccine supply constraints in 100 … Two decades of the HPV vaccine: its promise, progress, prospects …
-
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
11 Feb 2026 01:51 GMT
… Cancer, Non-small Cell Lung Cancer (NSCLC), and others. … Cancer, Non-small Cell Lung Cancer (NSCLC), and others … Cell Lung Cancer Market
Non-small Cell Lung Cancer Market … Xencor, Taiho Pharmaceutical, Madison Vaccines, MacroGenics, Zenith Epigenetics, …
About
© 1995-2026